文献速递消化系统肿瘤

早期胃癌非治愈性ESD切除术后的治疗策略

[The therapeutic strategy after noncurative endoscopic submucosal dissection for early gastric cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2019-01-01

本研究回顾107例早期胃癌非治愈性ESD患者,按后续治疗分为追加手术组41例和随访组66例。追加手术组未分化型、SM2浸润、脉管瘤栓更多,R0切除率更低。两组复发率、总生存率和无病生存率差异无统计学意义。结论认为需评估淋巴结转移风险,低风险且不耐受手术的老年患者可密切随访。

要点

  • 非治愈性ESD后需评估淋巴结转移风险以决定是否追加手术。
  • 追加手术组病理示肿瘤残留率31.7%、淋巴结转移率9.8%。
  • 低风险且不耐受手术的老年患者可考虑密切内镜随访。

核心结论

  • 非治愈性ESD切除后的早期胃癌患者需评估淋巴结转移风险。
  • 对于转移风险极低且身体状况难以耐受外科手术的老年患者,密切随访也是可选择的治疗策略之一。

研究设计与样本

  • 回顾性收集107例接受非治愈性ESD的早期胃癌患者,按后续治疗分为追加手术组41例和随访组66例。
  • 比较两组临床病理特征、短期及长期疗效。

主要发现

  • 追加手术组与随访组年龄分别为59.2±8.7岁和64.7±8.8岁(P=0.020),黏膜下层浸润深度分别为1445.83±803.12 μm和794.71±815.79 μm(P=0.010)。
  • 追加手术组未分化型、SM2浸润、Lauren弥漫型、脉管瘤栓和神经侵犯均较随访组多见(均P<0.05)。
  • 追加手术组ESD的R0切除率为26.8%,低于随访组的65.2%(P<0.001)。
  • 追加手术组病理示肿瘤残留率31.7%(13/41)、淋巴结转移率9.8%(4/41)。
  • 追加手术组与随访组复发率分别为4.9%(2/41)和7.6%(5/66),差异无统计学意义(P=0.883);总生存率和无病生存率差异亦无统计学意义(P=0.066和P=0.938)。

临床怎么用

  • 非治愈性ESD后应结合病理特征评估淋巴结转移风险,决定是否追加胃切除术。
  • 对高龄、合并症多、难以耐受手术且淋巴结转移风险极低的患者,可考虑密切内镜随访作为替代策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the therapeutic strategy in patients with early gastric cancer after noncurative endoscopic submucosal dissection (ESD). Methods: A total of 107 cases with early gastric cancer receiving noncurative endoscopic submucosal dissection were collected and the patients were classified into an additional gastrectomy group (n=41) and a simple follow-up group (n=66) according to the therapeutic method used after noncurative ESD. The clinicopathological information, short- and long-term clinical outcomes between the two groups were analyzed and compared. Results: The mean age of the patients in the gastrectomy group and follow-up group was(59.2±8.7)years old and(64.7±8.8)years old, respectively. The depth of submucosal invasion was (1445.83±803.12) and (794.71±815.79) μm, respectively. The difference between the two groups was statistically significant (P=0.020 for age and P=0.010 for depth of submucosal invasion). Compared with follow-up group, the patients with undifferentiated histologic type, deep invasion of submucosa (SM2), diffuse type, lymphovascular invasion and neural invasion were more common in the gastrectomy group (P<0.05). The R0 resection rate of ESD in the gastrectomy group was significantly lower than the follow-up group(26.8% vs 65.2%, P<0.001). The positive residual tumor rate and LNM rate of additional gastrectomy group were 31.7%(13/41)and 9.76%(4/41)according to the pathological results after gastrectomy. The gastrectomy group had 2 cases of local recurrence (2/41, 4.9%), while 5(5/66, 7.6%)in the follow-up group(4.9% vs 7.6%, P=0.883). There was no significant difference in overall survival (OS) and disease-free survival (DFS) between the two study groups (P=0.066 and 0.938, respectively). Conclusions: Assessment of LNM risk should be performed in patients with noncurative endoscopic resection. For patients with low risk of LNM who are intolerance of additional gastrectomy due to old age and comorbidities, close follow-up with endoscopy can be considered as an alternative. 目的: 探讨早期胃癌患者非治愈性内镜黏膜下剥离术(ESD)切除后的治疗策略。 方法: 将107例非治愈性ESD治疗的早期胃癌患者,根据ESD术后是否追加外科手术,分为追加手术组(41例)和随访组(66例),比较两组患者的临床病理特征、短期及长期疗效。 结果: 追加手术组和随访组患者的年龄分别为(59.2±8.7)岁和(64.7±8.8)岁,浸润黏膜下层(SM)深度分别为(1445.83±803.12)和(794.71±815.79)μm,两组差异均有统计学意义(P=0.020,P=0.010)。与随访组比较,追加手术组的未分化型、SM2浸润、Lauren分型弥漫型较多,脉管瘤栓和神经侵犯更多见,差异均有统计学意义(均P<0.05)。追加手术组ESD手术的R0切除率为26.8%,低于随访组(65.2%,P<0.001)。追加手术组ESD术后肿瘤残留率为31.7%(13/41),淋巴结转移率为9.8%(4/41)。追加手术组和随访组分别有2例和5例出现肿瘤复发,复发率分别为4.9%和7.6%,差异无统计学意义(P=0.883)。追加手术组和随访组的总生存率和无病生存率差异无统计学意义(P=0.066,P=0.938)。 结论: 非治愈性ESD切除后的早期胃癌患者,需评估淋巴结转移风险。对于转移风险极低且身体状况难以耐受外科手术的老年患者,密切随访也是可选择的治疗策略之一。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhou H, Guo CG, Chen YT, et al. [The therapeutic strategy after noncurative endoscopic submucosal dissection for early gastric cancer]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31770856. doi:10.3760/cma.j.issn.0253-3766.2019.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。